Individually Adapted Therapy Duration From 24 to 72 Weeks for the Treatment of a Chronic Hepatitis C Genotype 1 Infection With Peginterferon Alfa-2b Plus Ribavirin in Dependence of the Initial Concentration and the Decline of the HCV RNA.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms INDIV-2
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database).
- 12 Jul 2011 EudraCT reports actual initiation date 2006-05-31, actual end date is 2009-05-31.
- 18 Apr 2010 Results presented at the 45th Annual Meeting of the European Association for the Study of the Liver.